Changes in Trypanosoma cruzi-specific immune responses following treatment: surrogate markers of treatment efficacy

BACKGROUND: As many as 20 million people are living with Trypanosoma cruzi infection in Latin American, yet few receive any treatment. The major limitation in developing and evaluating potential new drugs for their efficacy is the lack of reliable tests to assess parasite burden and elimination. MET...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Laucella, Susana A., Mazliah, Damián Pérez, Bertocchi, Graciela, Alvarez, María G., Cooley, Gretchen, Viotti, Rodolfo, Albareda, María C., Lococo, Bruno, Postan, Miriam, Armenti, Alejandro, Tarleton, Rick L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2805187/
https://ncbi.nlm.nih.gov/pubmed/19877967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648072
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi